Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice
- 16 October 2014
- journal article
- review article
- Published by Springer Nature in Psychopharmacology
- Vol. 231 (22) , 4255-4270
Abstract
The primary antipsychotic-induced creatine kinase elevation (i.e., not due to neuroleptic malignant syndrome, extrapyramidal symptoms, etc.) is a poorly studied condition. The aims of the present study were to provide an overview of published cases with antipsychotic-induced creatine kinase elevation and give recommendations for the clinical practice. PubMed and EMBASE were searched for eligible trials, case series, and case reports. We set a threshold at ten times the upper normal limit of the creatine kinase value in order to define an elevation as significant. The prevalence of significant creatine kinase elevation ranged between 2 and 7 %. We found a total of 42 eligible cases. Men were overrepresented in our sample (81 %). Patients with myoglobinuria were more likely to be symptomatic (Fisher’s exact test, p = 0.006), whereas neither myoglobinuria (Mann-Whitney test, p > 0.10) nor symptoms (Mann-Whitney test, p = 0.64) were related to the magnitude of the creatine kinase (CK) elevation. In the majority of the cases, the antipsychotic medication was discontinued (86 %). Forced diuresis was given in 36 % of the patients. Eighty-three percent of the patients had no further complications. Only one case was found with a de novo acute renal failure. The discontinuation of the antipsychotic medication was a sufficient measure for the CK elevation to subside in the majority of the cases. Cases with myoglobinuria should eventually be treated more aggressively. Further recommendations for the clinical practice are presented.Keywords
This publication has 61 references indexed in Scilit:
- Aripiprazole-Associated Rhabdomyolysis in a Patient With SchizophreniaThe Journal of Neuropsychiatry and Clinical Neurosciences, 2011
- Elevated Creatine Kinase Levels With Second-Generation AntipsychoticsThe Journal of Neuropsychiatry and Clinical Neurosciences, 2011
- Clozapine versus other atypical antipsychotics for schizophreniaCochrane Database of Systematic Reviews, 2010
- Acute camptocormia induced by olanzapine: a case reportJournal of Medical Case Reports, 2010
- Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate2009
- The syndrome of rhabdomyolysis: Complications and treatmentEuropean Journal of Internal Medicine, 2008
- Marked Elevation of Creatine Kinase with Sertindole: A Case ReportPharmacopsychiatry, 2007
- Massive Creatine Kinase Elevations with Quetiapine: Report of Two CasesPharmacopsychiatry, 2006
- Rhabdomyolysis and Compartment Syndrome with Coadministration of Risperidone and SimvastatinJournal of Psychopharmacology, 2004
- Rhabdomyolysis and Acute Renal Failure During High-Dose Haloperidol TherapyRenal Failure, 1995